Jiangsu Zhengdan Chemical Industry Co., Ltd.
SZSE:300641.SZ
5.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,537.817 | 1,924.374 | 1,759.4 | 1,317.715 | 1,307.682 | 1,209.51 | 1,169.92 | 988.602 | 1,101.214 | 846.071 | 632.912 | 638.147 |
| Cost of Revenue
| 1,478.644 | 1,805.539 | 1,530.7 | 1,158.793 | 1,162.533 | 1,051.941 | 958.256 | 739.889 | 828.331 | 694.735 | 537.762 | 556.396 |
| Gross Profit
| 59.172 | 118.835 | 228.7 | 158.921 | 145.15 | 157.569 | 211.664 | 248.713 | 272.883 | 151.336 | 95.15 | 81.751 |
| Gross Profit Ratio
| 0.038 | 0.062 | 0.13 | 0.121 | 0.111 | 0.13 | 0.181 | 0.252 | 0.248 | 0.179 | 0.15 | 0.128 |
| Reseach & Development Expenses
| 22.42 | 17.069 | 53.21 | 45.365 | 45.276 | 42.159 | 36.612 | 32.591 | 43.176 | 27.43 | 24.763 | 0 |
| General & Administrative Expenses
| 10.16 | 14.11 | 13.233 | 7.774 | 7.869 | 7.966 | 10.734 | 9.142 | 9.739 | 4.012 | 38.839 | 30.711 |
| Selling & Marketing Expenses
| 8.332 | 7.515 | 8.136 | 32.619 | 26.07 | 24.328 | 23.819 | 23.812 | 19.475 | 17.982 | 11.875 | 14.968 |
| SG&A
| 18.493 | 21.626 | 21.369 | 40.392 | 33.939 | 32.294 | 34.554 | 32.954 | 29.215 | 21.994 | 50.714 | 45.679 |
| Other Expenses
| -1,530.163 | -1.007 | 0.198 | -1.638 | -0.312 | -0.141 | 9.182 | 1.594 | 0.325 | 2.047 | 0.041 | 1.56 |
| Operating Expenses
| 1,530.163 | 67.02 | 98.072 | 107.418 | 98.92 | 92.927 | 90.201 | 86.893 | 95.418 | 64.897 | 53.225 | 47.133 |
| Operating Income
| 7.654 | 66.177 | 120.876 | 50.346 | 46.051 | 69.163 | 117.276 | 158.826 | 164.509 | 60.554 | 23.776 | 15.547 |
| Operating Income Ratio
| 0.005 | 0.034 | 0.069 | 0.038 | 0.035 | 0.057 | 0.1 | 0.161 | 0.149 | 0.072 | 0.038 | 0.024 |
| Total Other Income Expenses Net
| 1.469 | -1.007 | 0.198 | -1.638 | -0.312 | -0.141 | 9.182 | -0.699 | -1.857 | 0.27 | 0.041 | 1.56 |
| Income Before Tax
| 9.123 | 65.17 | 121.074 | 48.709 | 45.739 | 69.023 | 126.458 | 158.127 | 162.652 | 60.824 | 23.817 | 17.107 |
| Income Before Tax Ratio
| 0.006 | 0.034 | 0.069 | 0.037 | 0.035 | 0.057 | 0.108 | 0.16 | 0.148 | 0.072 | 0.038 | 0.027 |
| Income Tax Expense
| -0.752 | 9.335 | 16.595 | 5.711 | 5.292 | 8.686 | 18.395 | 23.677 | 24.645 | 8.66 | 4.777 | 2.627 |
| Net Income
| 9.875 | 55.835 | 104.479 | 42.998 | 40.447 | 60.337 | 108.063 | 134.45 | 138.007 | 52.165 | 19.04 | 14.481 |
| Net Income Ratio
| 0.006 | 0.029 | 0.059 | 0.033 | 0.031 | 0.05 | 0.092 | 0.136 | 0.125 | 0.062 | 0.03 | 0.023 |
| EPS
| 0.02 | 0.11 | 0.21 | 0.088 | 0.083 | 0.12 | 0.24 | 0.36 | 0.38 | 0.14 | 0.053 | 0.041 |
| EPS Diluted
| 0.02 | 0.11 | 0.21 | 0.088 | 0.083 | 0.12 | 0.24 | 0.36 | 0.38 | 0.14 | 0.053 | 0.041 |
| EBITDA
| 97.401 | 137.733 | 194.808 | 95.601 | 92.728 | 119.032 | 168.369 | 210.523 | 218.385 | 122.769 | 42.792 | 35.288 |
| EBITDA Ratio
| 0.063 | 0.072 | 0.111 | 0.073 | 0.071 | 0.098 | 0.144 | 0.213 | 0.198 | 0.145 | 0.068 | 0.055 |